Clinical trial
Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Japanese Clinical Practice
NCT02147444 is registered in ClinicalTrials.gov with Tohoku University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-center, Prospective, Non-interventional, Observational Cohort Study to Investigate Effectiveness and Safety of Rivaroxaban on Prevention of Stroke and Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Japanese Clinical Practice
- Lead sponsor
- Tohoku University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 30, 2012
- Completion date
- Not reported
- Enrollment
- 7,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
non-valvular atrial fibrillation